Medicare Enrolled

Dr. Robin Medina-Reinhart, NP, FNP

Physician Assistant · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
7125 N CHESTNUT AVE STE 101, Fresno, CA 93720
5592067680
In practice since 2017 (8 years)
NPI: 1013444165 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Medina-Reinhart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Medina-Reinhart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Medina-Reinhart

Dr. Robin Medina-Reinhart is a physician assistant in Fresno, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Medina-Reinhart performed 768 Medicare services across 449 unique beneficiaries.

Between the years covered by Open Payments, Dr. Medina-Reinhart received a total of $13,766 from 46 pharmaceutical and/or device companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Medina-Reinhart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 14% volume in CA $13,766 industry payments

Medicare Practice Summary

Medicare Utilization ↗
768
Medicare services
Top 14% in CA for physician assistant
449
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
290 $71 $405
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
158 $52 $285
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
104 $0 $37
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
75 $8 $69
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
36 $2 $9
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
30 $1 $18
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
21 $35 $230
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
21 $26 $69
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
19 $68 $183
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
14 $27 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,766
Total received (2021-2024)
Avg $3,441/year across 4 years
Top 2% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
439
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,792 (56.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,973 (43.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,322
2023
$2,657
2022
$6,613
2021
$2,174

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$446
Amgen Inc.
$420
AstraZeneca Pharmaceuticals LP
$266
Ardelyx, Inc.
$191
Lilly USA, LLC
$138
PFIZER INC.
$97
Axsome Therapeutics, Inc.
$94
Novo Nordisk Inc
$71
Lundbeck LLC
$67
ViiV Healthcare Company
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$60
ABIOMED
$51
SHIELD THERAPEUTICS INC
$39
Astellas Pharma US Inc
$36
Phathom Pharmaceuticals, Inc.
$32
Exact Sciences Corporation
$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$32
Otsuka America Pharmaceutical, Inc.
$29
Hologic Sales and Service, LLC
$28
Merck Sharp & Dohme LLC
$26
Agile Therapeutics, Inc.
$21
Novartis Pharmaceuticals Corporation
$20
Regeneron Healthcare Solutions, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$15
MAYNE PHARMA COMMERCIAL LLC
$13
Top 3 companies account for 48.8% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$6,988
Amgen Inc.
$1,678
AbbVie Inc.
$1,251
AstraZeneca Pharmaceuticals LP
$667
Lilly USA, LLC
$376
Takeda Pharmaceuticals U.S.A., Inc.
$352
Novo Nordisk Inc
$284
Ardelyx, Inc.
$191
GlaxoSmithKline, LLC.
$182
Axsome Therapeutics, Inc.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
PFIZER INC.
$97
IDORSIA PHARMACEUTICALS US INC
$88
Otsuka America Pharmaceutical, Inc.
$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$74
Dynavax Technologies Corporation
$68
Lundbeck LLC
$67
ITI, Inc.
$65
ViiV Healthcare Company
$62
Nevro Corp.
$62
Astellas Pharma US Inc
$55
MAYNE PHARMA COMMERCIAL LLC
$53
Shield Therapeutics Inc
$52
ABIOMED
$51
Biohaven Pharmaceuticals, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$45
SHIELD THERAPEUTICS INC
$39
BOSTON SCIENTIFIC CORPORATION
$37
Eisai Inc.
$36
Amarin Pharma Inc.
$35
Phathom Pharmaceuticals, Inc.
$32
Exact Sciences Corporation
$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$32
Biohaven Pharmaceutical Holding Company Ltd.
$30
Hologic Sales and Service, LLC
$28
Ironwood Pharmaceuticals, Inc
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
Merck Sharp & Dohme LLC
$26
Scilex Pharmaceuticals Inc.
$22
Organon LLC
$22
Agile Therapeutics, Inc.
$21
Novartis Pharmaceuticals Corporation
$20
Qiagen, LLC
$18
Kowa Pharmaceuticals America, Inc.
$17
IRONWOOD PHARMACEUTICALS, INC
$15
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 72.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · APRETUDE · AREXVY · Aimovig · AirDuo Digihaler · Auvelity · BREZTRI · CAPLYTA · CREON · Cologuard Collection Kit · DUPIXENT · Dayvigo · EVENITY · EVKEEZA · FARXIGA · FASENRA · GARDASIL · Heplisav-B · IBSRELA · Impella · JARDIANCE · Kerendia · LEQVIO · LINZESS · LO LOESTRIN FE · Linzess · Livalo · MOUNJARO · NEXPLANON · NEXTSTELLIS · NURTEC ODT · Otezla · Ozempic · QUANTIFERON-TB GOLD PLUS · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · Senza · Superion · THINPREP 2000 PROCESSOR · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Twirla · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · WAVEWRITER ALPHA · Wegovy · XIFAXAN · ZEPBOUND · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for physician assistant in CA.

Looking for a physician assistant in Fresno?
Compare physician assistants in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
259
Per 100K population
25.6
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Medina-Reinhart is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with speaking/promotional industry engagement in the top 2% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Medina-Reinhart experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Medina-Reinhart performed 290 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Medina-Reinhart receive payments from pharmaceutical companies?
Yes. Dr. Medina-Reinhart received a total of $13,766 from 46 companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Medina-Reinhart's costs compare to other physician assistants in Fresno?
Dr. Medina-Reinhart's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Medina-Reinhart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →